ABC
BMRN icon

Associated Banc-Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History

Associated Banc-Corp’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12
Closed -$1K – 995
2020
Q2 		$1K Buy
+12
New +$1.19K ﹤0.01% 833

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Associated Banc-Corp's BMRN Position: Q3 2020 in Review

Associated Banc-Corp sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2020, closing a stake of 12 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in BMRN in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 496 funds tracked by Wall St. Rank hold BMRN as of Q3 2020.

  • Associated Banc-Corp reported no remaining BioMarin Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 12 BioMarin Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Associated Banc-Corp first reported a position in BioMarin Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Associated Banc-Corp's BioMarin Pharmaceuticals position peaked at $1K in Q2 2020.
  • 496 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2020.

Based on Associated Banc-Corp's 13F filing for Q3 2020, filed 12 Nov 2020.